MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

MDT

88.62

+1.08%↑

VEEV

280.06

-0.3%↓

A

121.12

+1.59%↑

WBA

11.52

0%↓

HQY

103.04

+1.28%↑

Search

Repligen Corp

Geschlossen

BrancheGesundheitswesen

128.37 3.42

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

122.95

Max

129

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

5.8M

Verkäufe

1.6M

169M

KGV

Branchendurchschnitt

466.89

39.564

Gewinnspanne

3.446

Angestellte

1,778

EBITDA

2.7M

36M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+45.68% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

29. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.1B

7.2B

Vorheriger Eröffnungskurs

124.95

Vorheriger Schlusskurs

128.37

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

Repligen Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

8. Juli 2025, 19:37 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

M3-Brigade Shares Fall on Merger With ReserveOne

8. Juli 2025, 23:45 UTC

Market Talk

Gold Edges Lower, Weighed by Higher Treasury Yields -- Market Talk

8. Juli 2025, 23:42 UTC

Market Talk

Nikkei May Rise as Yen Weakens -- Market Talk

8. Juli 2025, 23:27 UTC

Market Talk

Australian REITs Yet to Offer Enough Appeal -- Market Talk

8. Juli 2025, 23:27 UTC

Market Talk

Global Equities Roundup: Market Talk

8. Juli 2025, 23:21 UTC

Market Talk

Summerset Bull Lauds Strong 2Q Sales Volumes -- Market Talk

8. Juli 2025, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. Juli 2025, 22:29 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn to Pay A$1.5 Million in Cash and Shares

8. Juli 2025, 22:28 UTC

Akquisitionen, Fusionen, Übernahmen

Capricorn Metals Enters Binding Agreement to Buy Claw Gold Project

8. Juli 2025, 21:58 UTC

Market Talk

Kura Sushi Closely Watching U.S. Tariff Negotiations on Asian Goods -- Market Talk

8. Juli 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

8. Juli 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8. Juli 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

8. Juli 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8. Juli 2025, 19:53 UTC

Market Talk

Copper Posts Biggest One-Day Gain Ever to Hit Record on Tariff Chatter -- Market Talk

8. Juli 2025, 19:53 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8. Juli 2025, 19:45 UTC

Market Talk

Canada Unlikely to Succeed in Bid for Tariff-Free Trade With U.S. -- Market Talk

8. Juli 2025, 19:29 UTC

Market Talk

U.S. Consumer-Credit Growth Slowed in May -- Market Talk

8. Juli 2025, 19:20 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

8. Juli 2025, 19:11 UTC

Market Talk

Bank of Canada's Rate Cuts Deliver Muted Relief Along the Curve -- Market Talk

8. Juli 2025, 19:01 UTC

Market Talk

Oil Futures Gain With Support From Products -- Market Talk

8. Juli 2025, 18:49 UTC

Ergebnisse

Hershey Names New CEO, Continuing Leadership Shuffle. The Stock Falls. -- Barrons.com

8. Juli 2025, 18:41 UTC

Market Talk

Mexico's Inflation Seen Mixed in June -- Market Talk

8. Juli 2025, 18:38 UTC

Market Talk

Gold Falls as Markets Digest Details of Trump Tariffs -- Market Talk

8. Juli 2025, 18:23 UTC

Market Talk

Analysts Anticipate Lower Ethanol Inventories -- Market Talk

8. Juli 2025, 18:10 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8. Juli 2025, 18:10 UTC

Market Talk

Freeport-McMoRan Jumps on Trump Tariff Plan for Copper Imports -- Market Talk

8. Juli 2025, 17:24 UTC

Market Talk

Election, Dollar Seen as Potential Headwinds for Ibovespa -- Market Talk

8. Juli 2025, 17:06 UTC

Market Talk

KeyCorp and Regional Banks Set for a Catchup -- Market Talk

8. Juli 2025, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

Peer-Vergleich

Kursveränderung

Repligen Corp Prognose

Kursziel

By TipRanks

45.68% Vorteil

12-Monats-Prognose

Durchschnitt 181.27 USD  45.68%

Hoch 207 USD

Tief 150 USD

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Repligen Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

13 ratings

10

Buy

3

Halten

0

Sell

Technischer Score

By Trading Central

125.31 / 140.7Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

Strong Bearish Evidence

Langfristig

Strong Bearish Evidence

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.